Avalo Therapeutics (AVTX) Short Interest Ratio & Short Volume

Short interest is the volume of Avalo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 104,300 shares of AVTX short. Learn More on Avalo Therapeutics' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avalo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Avalo Therapeutics saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 104,300 shares, a decrease of 32.0% from the previous total of 153,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Avalo Therapeutics: RedHill Biopharma Ltd. (2.38%), Pieris Pharmaceuticals, Inc. (1.12%), Monopar Therapeutics Inc. (1.24%), Kiora Pharmaceuticals, Inc. (0.56%), Purple Biotech Ltd (1.18%), FSD Pharma Inc. (1.00%), Edesa Biotech, Inc. (0.69%), Imunon, Inc. (3.95%), Elevai Labs, Inc. (0.48%), Akari Therapeutics, Plc (0.03%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling AVTX is an investing strategy that aims to generate trading profit from Avalo Therapeutics as its price is falling. AVTX shares are trading down $0.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Avalo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVTX, twice per month. The most recent reporting period available is April, 30 2024.